Teenager rakes in thousands faking leukemia

It seems every year that at least one or two people make the news for having duped their neighbors and their community into believing they have cancer and that they should give them money. This year is proving no exception, as information is coming out that a West Texas teenager has done just that, collecting some $17,000 based on false claims that she was suffering from leukemia.

Ruth Angelica Gomez, an 18 year old recent graduate from a high school outside El Paso, Texas, is believed to have duped hundreds of people into donating money to her organization, which she called "Achieve the Dream Foundation." She ran a website and even gave motivational speeches and threw fundraisers in an effort to make money. Responding to word that Gomez had been unable to attend her own prom, a high school—not her own—even arranged a prom/fundraiser for her, setting her up with a limo ride, a prom dress donated by a local boutique, and Gomez herself named 'queen of the dance.'

For more on this repulsive story, see the report at CBS News.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap